Helen Torley - President and CEO, Halozyme Therapeutics, Inc

As of November 8, 2021


Helen Torley Net Worth

  • Net worth is estimated to be at least $42.03M
  • Owns at least 537,160 units of Halozyme Therapeutics, Inc stock
  • Sold an estimated value of $31.35M in the last 7 years at Halozyme Therapeutics, Inc

Helen Torley Compensation at Halozyme Therapeutics, Inc in 2020

  • Earned a $791,440 salary
  • Rewarded $2,500,018 in stock value and options
  • Received a total compensation of $6,518,876

Helen Torley Trading

  • Largest purchase of shares was 50,000 units , worth over $733K on November 8, 2021
  • Largest sale of shares was 50,000 units , worth over $2.39M on February 1, 2021
  • In total has made about 45 transactions over 7 years
  • Usually trades in February, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Helen Torley Mailing Address

  • Mailing address is C/o Onyx Pharmaceuticals, Inc. 249 East Grand Ave. South San Francisco CA 94080 CA

Halozyme Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Helen I. Torley 2020 $791,440 - $2,500,018 $2,500,001 $712,270 $15,147 $6,518,876
Helen I. Torley 2019 $761,000 - $2,184,130 $2,184,128 $712,296 $15,572 $5,857,126
Helen I. Torley 2018 $725,000 - $2,115,640 $2,115,631 $831,665 $11,733 $5,799,669
Elaine D. Sun 2020 $395,833 $150,000 $1,500,269 $1,000,008 $180,352 $133,399 $3,359,861
Laurie D. Stelzer 2020 $93,225 - $ $ $ $77,996 $171,221
Laurie D. Stelzer 2019 $495,000 $2,500 $750,016 $750,005 $231,660 $16,939 $2,246,120
Laurie D. Stelzer 2018 $470,000 - $575,018 $575,009 $323,489 $9,409 $1,952,925
Masaru Matsuda 2020 $440,000 $50,000 $500,019 $500,008 $203,940 $13,901 $1,707,868
Michael J. LaBarre 2020 $475,000 - $650,009 $650,007 $220,163 $15,018 $2,010,197
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm

Halozyme Therapeutics, Inc Insider Trading

  • The most recent transaction was 50,000 units sold on November 8, 2021 by Helen Torley worth over $1.99M
  • In the last 14 years, insiders at Halozyme Therapeutics, Inc sold an estimated value of $129.21M and bought an estimated value of $81.29M
  • The most active traders are Helen Torley, President and CEO,  Gregory Ian Frost, CEO,  and Randal J Kirk
  • Insider trading is most common in February, with the busiest year in 2007

HALOZYME THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1